Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...

When drugmakers pulled the weight-loss drug fen-phen off the market in 1997, my mom was devastated. Not because the FDA ...

More than half of respondents to a survey were unaware that bariatric surgery may improve some women’s chances of getting ...

Welcoming a newborn is something many couples dream of doing, but it can get complicated when conceiving becomes a roadblock.

Reduction seen in risk for readmission, wound dehiscence, and hematoma, but no significant differences seen in rates of infection, bleeding ...

Data from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

Amgen presented data about its obesity drug at JP Morgan 2025, stating it hopes the once-monthly dosing will make it an attractive therapy.

Welcoming a newborn is something many couples dream of doing, but it can get complicated when conceiving becomes a roadblock.

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...